Monday, May 20, 2024
HomeNewsSCI Stem Cell Clinical Trial Awarded $25 Million Dollars

SCI Stem Cell Clinical Trial Awarded $25 Million Dollars

| Source: jdsupra.com

The California Institute for Regenerative Medicine (CIRM) has recently awarded $25 million dollars to “the first clinical trial based on cells derived from human embryonic stem cells that has been approved by the Federal Drug Administration (FDA).” This clinical trial has been specifically designed to benefit spinal cord injury (SCI) patients. Every year, 12,000 Americans suffer SCIs that permanently alter the quality of their lives.

CIRM has never before funded “stem-cell derived therapy research.” The institute will rely on the Geron Corporation to run this trial.

Please see full article below for more information.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

- Advertisment -

Must Read

Managing Pressure Injuries – Free Course on Cortree from SCIO

Pressure injuries are a health concern for many people with spinal cord injuries and other disabilities. As we age, our level of mobility and...